Latest News about CORT
Recent news which mentions CORT
Corcept Therapeutics' FDA-Approved Korlym Hits Main Goal In Cushing's Syndrome Patients With Difficult-To-Control Diabetes
December 13, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 30, 2024
From Benzinga
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
September 30, 2024
From Benzinga
Forecasting The Future: 6 Analyst Projections For Corcept Therapeutics
September 18, 2024
Tickers
CORT
From Benzinga
Tickers
CORT
From InvestorPlace
7 Biotech Stocks to Boost Your Portfolio to Peak Health
June 26, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
CORT
From InvestorPlace
Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
April 22, 2024
From Benzinga
What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday?
February 16, 2024
From Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
From Benzinga
Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
January 22, 2024
From Benzinga
Crude Oil Down 2%; Tesla Deliveries Top Estimates
January 02, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.